Home › Graves Disease › Texas › San Antonio
Graves Disease clinical trials in San Antonio, TX
6 studies for Graves Disease are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
RecruitingPhase 3
- Consano Clinical Research, Shavano Park · 12 mi away
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
RecruitingPhase 3
- Site-057, San Antonio
- Site-036, Shavano Park · 12 mi away
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
RecruitingPhase 2
- Site 116, San Antonio
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RecruitingPhase 2
- Site Number - 1014, San Antonio
- Site Number - 1052, San Antonio
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RecruitingPhase 2
- Site Number - 1011, San Antonio
Study of BHV-1300 in Graves' Disease
RecruitingPhase 1
- Site-105, Shavano Park · 12 mi away
Graves Disease trials in other cities
- Miami, FL7 studies
- Dallas, TX7 studies
- Houston, TX6 studies
- San Francisco, CA3 studies
- Las Vegas, NV3 studies
- Torrance, CA3 studies
- Asheville, NC3 studies
- Akron, OH3 studies
- Farmington Hills, MI3 studies
- Kansas City, MO3 studies
- McKinney, TX3 studies
- Havelock, NC3 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Breast Cancer46 studies
- Colorectal Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity40 studies
- Type 2 Diabetes36 studies
- Overweight34 studies
- Pancreatic Cancer31 studies
- Ovarian Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.